Cargando…
Publisher Correction to: delivery systems of CRISPR/Cas9-based cancer gene therapy
Autores principales: | Biagioni, Alessio, Laurenzana, Anna, Margheri, Francesca, Chillà, Anastasia, Fibbi, Gabriella, Del Rosso, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495516/ https://www.ncbi.nlm.nih.gov/pubmed/31068977 http://dx.doi.org/10.1186/s13036-019-0169-0 |
Ejemplares similares
-
Delivery systems of CRISPR/Cas9-based cancer gene therapy
por: Biagioni, Alessio, et al.
Publicado: (2018) -
Type II CRISPR/Cas9 approach in the oncological therapy
por: Biagioni, A., et al.
Publicado: (2017) -
Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: the amoeboid angiogenesis
por: Chillà, Anastasia, et al.
Publicado: (2018) -
Cell-Mediated Release of Nanoparticles as a Preferential Option for Future Treatment of Melanoma
por: Chillà, Anastasia, et al.
Publicado: (2020) -
CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines
por: Biagioni, Alessio, et al.
Publicado: (2021)